COVID patients receiving antibiotics worsened global antimicrobial resistance

  28 May 2022

Over the course of the pandemic, millions of people around the world have been admitted to hospitals with COVID-19. And, because coronavirus symptoms can be hard to distinguish from pneumonia and other bacterial infections, many of these patients are prescribed broad-spectrum antibiotics.

In a recent published study, researchers with Alberta’s  Antimicrobial Resistance (AMR) – One Health Consortium have found this common hospital practice may be acting “as a catalyst” to increase global antimicrobial resistance (AMR).

Further reading: University of Calgary
Author(s): University of Calgary
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed